RNS Number : 9970E
Stenprop Limited
10 July 2019




(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP


("Stenprop" or the "Company")






10 July 2019


Shareholders are referred to the announcement released on SENS on 8 July 2019, relating to the exercise of vested nil cost options awarded under the Stenprop Limited Amended Deferred Share Bonus Plan ("Deferred Bonus Plan") and are advised that the disclosure in respect of Neil Marais was incorrectly stated as 11,903 nil cost options having been exercised. The actual number of nil cost options that were exercised in terms of the Deferred Share Bonus Plan was 23,468 (at a deemed value of GBP 1.11 per nil cost option), resulting in a total transaction value of GBP 26,049.48.


The Company intends to utilise treasury shares to settle the exercise of the nil cost options by Neil Marais, following which the total number of treasury shares held by the Company will be 15,937,130 ordinary shares and the total number of shares in issue less shares held in treasury will be 282,838,045.


For further information:


Stenprop Limited

Paul Arenson
James Beaumont
Julian Carey

44(0)20 3918 6600


Numis Securities Limited (Financial Adviser)

Hugh Jonathan
Vicki Paine

44(0)20 7260 1000


JSE Sponsor

Java Capital Trustees and Sponsors Proprietary Limited

27 (0) 11 722 3050


About Stenprop

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.